Fibrinolysis in acute and chronic cardiovascular disease

N Kietsiriroje, RAS Ariëns… - Seminars in thrombosis …, 2021 - thieme-connect.com
The formation of an obstructive thrombus within an artery remains a major cause of mortality
and morbidity worldwide. Despite effective inhibition of platelet function by modern …

Endogenous fibrinolysis: an important mediator of thrombus formation and cardiovascular risk

ON Okafor, DA Gorog - Journal of the American College of Cardiology, 2015 - jacc.org
Most acute cardiovascular events are attributable to arterial thrombosis. Plaque rupture or
erosion stimulates platelet activation, aggregation, and thrombosis, whilst simultaneously …

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

M Ząbczyk, RAS Ariëns, A Undas - Cardiovascular research, 2023 - academic.oup.com
Fibrinogen conversion into insoluble fibrin and the formation of a stable clot is the final step
of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated …

Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes

M Ząbczyk, J Natorska, A Undas - Journal of clinical medicine, 2021 - mdpi.com
Fibrin is a major component of thrombi formed on the surface of atherosclerotic plaques.
Fibrin accumulation as a consequence of local blood coagulation activation takes place …

Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? JACC Review Topic of the Week

DA Gorog, GYH Lip - Journal of the American College of Cardiology, 2019 - jacc.org
Endogenous fibrinolysis is a powerful natural defense mechanism against lasting arterial
thrombotic occlusion. Recent prospective studies have shown that impaired endogenous …

Fibrinolysis and the control of blood coagulation

JC Chapin, KA Hajjar - Blood reviews, 2015 - Elsevier
Fibrin plays an essential role in hemostasis as both the primary product of the coagulation
cascade and the ultimate substrate for fibrinolysis. Fibrinolysis efficiency is greatly …

Enhanced spontaneous thrombolysis: a new therapeutic challenge

IB Kovacs, DA Gorog, J Yamamoto - Journal of thrombosis and …, 2006 - Springer
Spontaneous thrombolysis is an endogenous protective mechanism against lasting arterial
thrombotic occlusion, which is implicated in the pathogenesis of myocardial infarction and …

Novel or expanding current targets in fibrinolysis

T Wyseure, PJ Declerck - Drug discovery today, 2014 - Elsevier
Highlights•Despite the availability of revascularization strategies the care of heart disease
and stroke patients remains challenging.•There is an unmet clinical need to explore novel …

Endogenous fibrinolysis—Relevance to clinical thrombosis risk assessment

R Kanji, J Kubica, EP Navarese… - European Journal of …, 2021 - Wiley Online Library
The development of an obstructive luminal thrombus is pathological and considered a
failure of endogenous fibrinolysis. The consequences may be fatal, or result in lasting …

Fibrinogen and catheter-directed thrombolysis

RL Ross, AW Beck - Seminars in Vascular Surgery, 2014 - Elsevier
Fibrinogen is a complex glycoprotein that is known to play a significant role in the process of
thrombus formation and evolution, and has been linked to the pathophysiology of …